Eveready Industries India Ltd Q4 FY26 Earnings Analysis

Published 25 May 2026 | Household Products | Market Cap: ₹2.3K Cr

Price

320

Market Cap

₹2.3K Cr

P/E Ratio

15.9

Earnings Summary

- Steady growth: Last 5 quarters showed consecutive growth, reversing a decade of negative trends; current CAGR around 4%-5%. - Eveready Industries has shown steady growth over the past 5 quarters, with improving growth percentages quarter-on-quarter.

📊 Revenue & Sales Performance

- Steady growth: Last 5 quarters showed consecutive growth, reversing a decade of negative trends; current CAGR around 4%-5%. - Alkaline battery segment: Expect aggressive growth (previously 70%+ growth); market share increasing (currently 19% and rising). - Jammu plant: Operational ramp-up expected to start at 25%-30% capacity utilization, moving to 40%-50% in 2 years; practical capacity ~350 million units. - Overall volumes: YTD battery sales close to 1 billion units with 4%-4.5% YoY growth; alkaline contributes significantly to incremental growth. - New categories: Expansion into mobile accessories, mosquito rackets, lithium batteries; currently contributing to over 10% top-line growth. - Margin improvement: Premiumization and local manufacturing to enhance margins; price increases and cost controls support profitability. - 3-year outlook: Difficult to predict exact CAGR due to commodity and currency volatility, but momentum and category expansions are positive indicators.

📈 Profitability & Margins

- Eveready Industries has shown steady growth over the past 5 quarters, with improving growth percentages quarter-on-quarter. - The company expects to maintain growth momentum in the near term, targeting premiumization to aid margin improvement. - Management is optimistic about achieving double-digit growth in some segments as RTM stabilizes and new product categories gain traction. - The Jammu alkaline battery plant is expected to start with 20-30% capacity utilization and ramp up to 40-50% in 2 years, supporting revenue growth. - The alkaline battery plant is projected to breakeven from day one and is expected to improve margins by about 10%. - Though headwinds like commodity prices and currency fluctuations persist, management believes these can be offset by price hikes and operational improvements. - No formal 3-year CAGR target was declared, but sustained top-line growth above current ~10% is anticipated with margin expansion.

🏗️ Capital Expenditure Plans

- The Jammu plant investment is substantial, with about INR180 crore approved and ~90% already done; construction is nearly complete and trials are ongoing. - The Jammu plant has a practical capacity of 350 million units, with current utilization around 60-70 million and an aim for 20-30% utilization initially, ramping up to 40-50% over 2 years. - Alkaline battery manufacturing facility is operational and expected to breakeven from day one, with domestic manufacturing expected to improve operating margins by ~10%. - Future capex largely linked to plant and machinery, with potential GST-linked subsidies up to 3x of plant and machinery investment, pending government approvals and registration under the Jammu national incentive scheme. - New product launches are ongoing, including mobile accessories and lithium batteries, aiming to leverage the existing distribution system. - Noida land monetization planned to raise approximately INR250 crores, primarily to reduce debt and optimize operating expenses.

💰 Fundraising & Capital Structure

- The company is focusing on strengthening its balance sheet with debt reduction being a key priority. - The Board approved divestment of a non-core land parcel at Noida primarily aimed at enhancing financial flexibility and reducing debt. - There is no explicit mention of any immediate new debt fundraising. - Equity issuance is not currently planned; however, an investor suggested considering equity dilution to capitalize on growth, but management only noted the suggestion without confirming plans. - Employee Stock Options Plan (ESOP) has been initiated as a mechanism to align employee and shareholder interests but is not a fundraising event. - Overall, no confirmed plans for new fundraising via debt or equity were stated, but the company remains open to optimizing operations and opportunities as they arise.

📋 Order Book & Pipeline

The transcript does not explicitly mention any details about the current or expected order book or pending orders for Eveready Industries India Limited. However, related operational updates include: - The Jammu alkaline battery plant is on track for completion by the end of FY26, with around 20%-30% utilization expected in year 1, ramping up to 40%-50% in year 2. - The alkaline portfolio is growing rapidly, with volumes reaching almost 19% market share and a 72% growth aided by power-intensive device demand. - The company is actively following up on government incentives/subsidies for the Jammu plant to support investment and sales growth. - New product launches in mobile accessories and mosquito rackets are underway, aimed at leveraging existing distribution channels. - Manufacturing operations remain stable and uninterrupted, supporting continued growth momentum. No quantitative order backlog or pending order figures were disclosed.

Key Metrics

Frequently Asked Questions

What were Eveready Industries India Ltd Q4 FY26 results?

- Steady growth: Last 5 quarters showed consecutive growth, reversing a decade of negative trends; current CAGR around 4%-5%. - Eveready Industries has shown steady growth over the past 5 quarters, with improving growth percentages quarter-on-quarter.

What is Eveready Industries India Ltd share price analysis?

Eveready Industries India Ltd currently shows a neutral. The stock trades at a P/E of 15.9 with a market cap of ₹2,326. Investors should review the full earnings analysis for detailed insights.

Is Eveready Industries India Ltd planning capital expenditure?

- The Jammu plant investment is substantial, with about INR180 crore approved and ~90% already done; construction is nearly complete and trials are ongoing.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.